Novo Nordisk and Biomarin make peace in strife over employees and confidentiality

A court strife between Novo Nordisk and Biomarin on business secrets and the recruitment of central Novo Nordisk employees has been concluded outside of court, according to Børsen.
Photo: Stine Tidsvilde
Photo: Stine Tidsvilde

Novo Nordisk and the US-based biotech firm Biomarin have settled their court fight in the battle for the hemophilia market, according to Danish newspaper Børsen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading